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A  65-year-old  woman,  with  valvular  heart  disease,  atrial  ﬁbrillation,  and  depression,  presented  to  the
emergency  room  due  to dyspnea  with  shock  state  accompanied  by agitation.  An  electrocardiogram
showed  ST  segment  elevation  in  leads  II, III, aVF, I, aVL, and V4–6. An  echocardiography  revealed  exten-
sive  akinesis  in  the  apex,  but  hyperkinesis  in the  base,  with  apical  ballooning  appearance.  An  emergent
coronary  angiography  showed  no obstructive  disease.  The  patient  required  intubation  under  mechanical
ventilator,  and  an  intra-aortic  balloon  pump  to recover  from  shock  state.  She  had  been  taking  mapro-
tiline,  a tetracyclic  antidepressant,  and  had  added  dextromethorphan,  a  cough  suppressant,  just  before
admission.  The  patient  was diagnosed  with  takotsubo  cardiomyopathy  associated  with  serotonin  syn-
drome  due  to serotonergic  drug  interactions.  After  discontinuation  of  these  drugs  and  administration
of  serotonin  antagonist  under  mechanical  supportive  care,  she  became  hemodynamically  stable.  Apical
ballooning  was  completely  resolved  2 weeks  later,  and  she  was discharged  well.  We  diagnosed  serotonin
syndrome  manifesting  as  excessive  serotonin  toxicity  that  resulted  in  a hyperserotonergic  and  hyperad-
renergic  state,  causing  takotsubo  cardiomyopathy.  Here,  we  report  a case  of takotsubo  cardiomyopathy
associated  with  serotonin  syndrome.  This  case  suggests  that  serotonin  syndrome  should  be  recognized
promptly  and  complications,  including  takotsubo  cardiomyopathy,  need  to be treated  appropriately.
<Learning  objective:  We  must  closely  monitor  serotonergic  agents  because  serotonin  syndrome  can
occur from  a combination  some  serotonergic  drugs,  even  when  each  is  used  at  a therapeutic  dose.  Sero-
tonin  syndrome  can  lead  to  not  only  serotonergic  but  also  hyperadrenergic  state  that  may  be  a  trigger  of
takotsubo  cardiomyopathy.  Serotonin  syndrome  should  be diagnosed  surely  to  ensure  the  prompt  initia-
tion of  the  treatment  included  discontinuation  of  the precipitating  drugs  because  the  disease  occasionally
progresses  rapidly  to  fatal  condition.>
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Takotsubo cardiomyopathy, or apical ballooning syndrome, is
haracterized by transient left ventricular (LV) dysfunction, com-
only involving the apex and associated with emotional or physical
tress, without any obstructive coronary artery disease. Common
linical presentations of this condition are chest pain and dyspnea
imicking acute myocardial infarction, but pulmonary edema and
ardiogenic shock are infrequent [1]. Myocardial stunning medi-
ted by catecholamine excess is the predominant theory explaining
he disease mechanism [2].  Serotonin syndrome is a potentially
ife-threatening condition associated with excessive serotonergic
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activity in the nervous system caused by overdose with one seroto-
nergic drug or the improper combination of these drugs. Classically,
it is characterized by a clinical triad of mental status changes, auto-
nomic instability, and neuromuscular hyperactivity [3].  Overdose
with some antidepressants, such as a serotonin–norepinephrine
reuptake inhibitor, leads to takotsubo cardiomyopathy indepen-
dently of serotonin syndrome [4–7]. Only one case has been
reported of serotonin syndrome due to overdose of combined
antidepressants that induced takotsubo cardiomyopathy [8].  We
report the case of a patient who  presented with cardiogenic shock
due to takotsubo cardiomyopathy associated with serotonin syn-
drome caused by drug interactions.Case report
A 65-year-old female with history of depression, valvular
heart disease (moderate mitral and aortic valve stenosis), and
vier Ltd. All rights reserved.
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(ig. 1. Chest radiography on admission shows congestive heart failure with marked
ardiomegaly and consolidation in both lower lobes.
trial ﬁbrillation with normal LV function that had been well
ontrolled with verapamil, bisoprolol, and warfarin, presented to
ur hospital. She had been diagnosed with depression 4 weeks
efore admission and started maprotiline at that time, gradually
ncreasing from 10 mg  to 30 mg  once a day. She had noticed cough
nd fever 3 days prior to admission to our hospital. She went to a
ocal clinic and was diagnosed with acute bronchitis. Amoxicillin
nd dextromethorphan were prescribed additionally at that time.
owever she was admitted to the hospital by ambulance because
f severe dyspnea and hemosputum. On the patient’s arrival, her
lood pressure was found to be 83/44 mmHg; her heart rate, 166
eats/min; her oxygen saturation level, 91% on an oxygen mask
ith reservoir bag at 10 l per minute; her body temperature,
9.8 ◦C. A chest radiography showed severe pulmonary congestion
nd consolidation in both lower lobes (Fig. 1). An electrocardio-
ram showed ST segment elevation in leads II, III, aVF, I, aVL, and
4–6 (Fig. 2A). An echocardiography revealed extensive akinesis in
he apex but hyperkinesis in the base, with an apical ballooning
ppearance (Fig. 3A). Blood tests revealed signiﬁcant elevation
f creatine kinase (CK) 2030 IU/l (normal range, 57–115 IU/l), but
K-MB fraction elevated 28 IU/l (normal range, 4–13 IU/l) slightly,
urthermore white blood cell count 13,700/mm3, and C-reactive
rotein was 25.1 mg/dl. She required intubation under mechanical
ig. 3. Echocardiography on admission and 2 weeks later. Upper: On admission. Triangle
hase; (B) end-systolic phase on admission. Lower: Two  weeks after admission. Abnorma
C)  End-diastolic phase; (D) end-systolic phase.Fig. 2. Electrocardiography (ECG) on and after admission. (A) ECG on admission
shows ST segment elevation in leads II, III, aVF, I, aVL, and V4–6. (B) ST elevation
resolved and inverted negative T wave in same leads on the third day.
ventilation support and was started on intravenous catecholamine
(dobutamine 8 g/kg/min and noradrenaline 0.2 g/kg/min). She
underwent emergent coronary angiography to exclude acute coro-
nary syndrome. Her coronary angiogram showed normal coronary
arteries without any obstruction. Finally, she was diagnosed with
takotsubo cardiomyopathy. For treatment, an intra-aortic balloon
pump (IABP) was inserted to maintain her blood pressure. The
next day, physical examination showed persistent hypotension,
hyperthermia (41.7 ◦C), muscle rigidity in the extremities, and
s indicate the areas of akinesis that appeared as apical ballooning. (A) End-diastolic
lities of left ventricular motion completely resolved with ejection fraction of 0.64.
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cular clonus. As serotonin syndrome was suspected based on her
edical history and clinical signs, midazolam was  administered
ntravenously and cyproheptadine was administered via naso-
astric tube. On the third day her fever was alleviated and she
chieved hemodynamic stability. CK was still high at 607 IU/l with
ormalized CK-MB 10 IU/l. Electrocardiography showed negative T
aves of the prior ST elevated leads (Fig. 2B). On the 7th day, IABP
nd catecholamine support were withdrawn. Two weeks later
chocardiography showed complete resolution of wall-motion
bnormalities with an estimated LV ejection fraction of 0.65
Fig. 3C and D). She was discharged in good health on the 53rd day.
iscussion
We  present the case of a patient who suffered potentially fatal
ardiogenic shock caused by takotsubo cardiomyopathy due to
erotonin syndrome. Takotsubo cardiomyopathy, also known as
tress-induced cardiomyopathy or broken-heart syndrome, is char-
cterized by transient dysfunction of the LV apex, concomitant
ith hyperkinesis of the basal ventricle, with apical balloon-
ng, but no coronary artery obstruction [1].  Several etiologies
ave been proposed for the condition, such as coronary spasm,
ympathetic hyperactivity, microcirculatory failure, and excessive
atecholamine-induced myocardial stun [2].  Although the progno-
is of takotsubo cardiomyopathy is generally favorable, cardiogenic
hock has been found to occur in 4.2% of such cases and in-hospital
ortality is 1.1% [1].
Serotonin syndrome manifests as a clinical triad of mental-
tatus changes, autonomic hyperactivity, and neuromuscular
bnormalities due to excess serotonergic activity in the central
nd peripheral nervous system [3].  The present case was diagnosed
sing the Hunter Serotonin Toxicity Criteria, and the identiﬁcation
f mild muscle rigidity, ocular clonus, and agitation with hyperther-
ia  [3].  Although there are no speciﬁc laboratory tests to conﬁrm
he diagnosis of the serotonin syndrome, laboratory abnormalities
hat develop in severe cases include an elevated CK, and inﬂamma-
ory markers that corresponded with coexisting symptoms with
yperthermia, muscle rigidity, and agitation in this case. Patients
ith serotonin syndrome usually have vital-sign abnormalities,
uch as tachycardia, hypertension, and hyperthermia. However
he present case presented with shock status due to poor car-
iac function except hyperkinetic contraction of the basal ventricle.
hese ﬁndings were compatible with takotsubo cardiomyopathy.
23I-metaiodobenzylguanidine myocardial scintigraphy evaluates
ardiac sympathetic nervous function, and the usefulness of imag-
ng has been evaluated in takotsubo cardiomyopathy [9].  However
e did not perform myocardial scintigraphy because of the insta-
ility of the patient’s condition. In the case of cardiogenic shock
ssociated with takotsubo cardiomyopathy, we must exclude LV
utﬂow tract obstruction associated with hyperkinetic movement
f sigmoid septum. This is because inotropes and IABP may  amplify
he intra-ventricular gradient. In the present case, no outﬂow
bstruction was detected by echocardiography.
Patients with stress-induced cardiomyopathy frequently have
vidence of exaggerated sympathetic activation, including high
evels of plasma catecholamine, serotonin, and other neuronal
etabolites [2].  Serotonin syndrome can lead to a hyperadrenergic
tate and the triggering of takotsubo cardiomyopathy in these
ases. Maprotiline is known as a tetracyclic antidepressant with
trong selective norepinephrine reuptake inhibitor effects but
nly weak effects on serotonin and dopamine reuptake. The
atient in the present case had received dextromethorphan in
ddition to maprotiline. Dextromethorphan, a commonly used
ough suppressant, is an opioid receptor agonist, N-methyl-d-
spartate (NMDA) glutamase receptor antagonist, and serotonin
[logy Cases 7 (2013) e1–e3 e3
reuptake inhibitor. It is well-known that this drug can lead to
serotonin syndrome [10]. In the present case, the combination of
maprotiline and dextromethorphan might have caused serotonin
syndrome [3].  The relationship between serotonin syndrome and
takotsubo cardiomyopathy has not been clariﬁed to date. Mehta
et al. suggested in their case report that serotonin syndrome can
lead to physiologic stress due to a hyperadrenergic state, and the
hyperadrenergic state can lead to stress-induced cardiomyopathy
[8]. Another possibility is that excessive serotonin levels directly
overstimulate serotonin receptors in the heart [8].  Furthermore,
antidepressant medications have been shown to inﬂuence plasma
catecholamine levels. Overdose of these drugs or improper com-
binations of them have led to the development of takotsubo
cardiomyopathy independently of serotonin syndrome [4–7].
Elevated serum catecholamine and serotonin levels have been
extensively described in stress-induced cardiomyopathy [3].
The management of serotonin syndrome includes discontinu-
ation of the precipitating drugs, provision of supportive care, and
control of agitation, autonomic instability, and hyperthermia [3].  In
the present case, discontinuation of antidepressants and adminis-
tration of cyproheptadine, a serotonin antagonist, improved hyper-
thermia and stabilized hemodynamics on the day after admission.
Benzodiazepine was useful in controlling excessive muscle activity.
Although serotonin syndrome is a potentially life-threatening con-
dition, more than 85% of clinicians are unaware of the diagnosis [3].
Furthermore, serotonin syndrome does not resolve spontaneously,
as long as the precipitating agents continue to be administered. The
condition occasionally progresses rapidly to death.
The present patient had received medical treatment for atrial
ﬁbrillation with moderate valvular disease for about a decade.
Tachyarrhythmia and hyperthermia due to serotonin syndrome,
in addition to takotsubo cardiomyopathy, can deteriorate to con-
gestive heart failure following a rapid ventricular response of
preexisting atrial ﬁbrillation. The present case suggests that a
therapeutic dose of maprotiline, with a concomitant therapeutic
dose of dextromethorphan, is required for the occurrence of sero-
tonin syndrome. An irritable condition, characterized by symptoms
including agitation, hyperthermia, and tachycardia can result from
serotonin syndrome and deteriorate to takotsubo cardiomyopathy
associated with continuous adrenergic and serotonergic stimula-
tion. This case study demonstrates that clinicians must closely
monitor serotonergic drugs to ensure the prompt initiation of treat-
ment for serotonin syndrome.
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